Bullish Moving Averages
16
Bearish Moving Averages
0
Products
Investments
Back Stocks profile
Today’s low
999.60Today’s High
1023.8052W low
763.0052W High
1092.00Open Price
1005.00Prev. Close
927.2000Volume
1054127.00Value
1056709611.15Market Cap Cr
34596.00
Price to Earnings
101.70
Price to Book Value
7.90
Dividend Yield
0.00
PE to Growth
-10.00
Op Revenue TTM Cr
46576.22
Net Profit TTM Cr
340.08
Cash From Operating Activity Cr
6106.95
Return on Equity %
8.79
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
04 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
1017.58
Second Resistance
1032.72
Third Resistance
1041.68
First Support
993.48
Second Support
984.52
Third Support
969.38
Relative Strength Index
58.77
Money Flow Index
41.84
MACD
5.96
MACD Signal
2.93
Average True Range
25.31
Average Directional Index
11.09
Rate of Change (21)
11.06
Rate of Change (125)
7.54
Commodity Channel Index
139.6
Williams %R
-37.3
BETA
1 Month
0.63
3 Month
0.72
1 Year
0.55
3 Year
0.18
PRICE CHANGE ANALYSIS
1 Week
Low
High
966.65
1023.75
1 Month
Low
High
864
1023.75
3 Months
Low
High
864
1092
6 Months
Low
High
854.25
1092
1 Year
Low
High
763
1092
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 4.76 | 5.52 | 6.32 | 5.12 | 10.59 | 16.99 | 17.85 | 12.80 | 15.33 | 13.63 | 14.85 | |
Operating Expenses Qtr | 8.36 | 7.82 | 8.73 | 6.67 | 8.23 | 8.97 | 9.45 | 9.12 | 13.90 | 9.33 | 8.86 | |
Operating Profit Qtr | -3.85 | -2.30 | -2.41 | -1.59 | 2.23 | 8.01 | 8.19 | 3.61 | 0.76 | 3.93 | 5.43 | |
EBIDT Qtr Cr | -3.60 | -2.30 | -2.41 | -1.55 | 2.36 | 8.02 | 8.40 | 3.68 | 1.43 | 4.30 | 5.99 | |
Depreciation Qtr | 0.31 | 0.32 | 0.37 | 0.59 | 0.73 | 0.75 | 0.79 | 0.83 | 0.83 | 0.83 | 0.83 | |
Net Profit Qtr | -3.68 | -2.47 | -2.72 | -2.37 | 1.99 | 5.34 | 4.79 | 1.76 | -0.90 | 2.47 | 3.53 | |
Basic EPS Qtr | -0.11 | -0.07 | -0.08 | -0.07 | 0.06 | 0.15 | 0.14 | 0.05 | -0.03 | 0.07 | 0.10 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 21.72 | 58.23 | 202.06 | 307.80 | 495.02 | |
Operating Expenses Annual Cr | 31.58 | 35.78 | 51.36 | 174.32 | 88.60 | |
Operating Profit Annual | -10.15 | 22.04 | 148.34 | 132.05 | 406.33 | |
Operating Profit Margin Annual % | -46.73 | 37.85 | 73.41 | 42.90 | 82.08 | |
Total Expenses Annual Cr | 33.28 | 38.99 | 54.97 | 178.34 | 98.69 | |
EBIDT Annual Cr | -9.86 | 22.46 | 150.69 | 133.48 | 406.42 | |
EBIDT Annual margin % | -45.40 | 38.56 | 74.58 | 43.37 | 82.10 | |
Depreciation | 1.59 | 3.10 | 3.48 | 3.80 | 9.89 | |
PAT Before ExtraOrdinary Items Annual Cr | -11.24 | 13.87 | 102.62 | 99.23 | 272.55 | |
Net Profit Annual | -11.24 | 13.87 | 102.62 | 99.23 | 272.55 | |
Basic EPS Annual | -0.33 | 0.40 | 2.97 | 3.38 | 10.12 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 6752.07 | 6763.40 | 6749.59 | 6645.46 | 2280.32 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 11.67 | 11.19 | 17.14 | 16.12 | 140.84 | |
Total Current Liabilities Annual Cr | 5.87 | 5.81 | 10.28 | 14.96 | 104.40 | |
Total Capital Plus Liabilities Annual Cr | 6769.61 | 6780.41 | 6777.02 | 6676.55 | 2525.56 | |
Fixed Assets Annual | 2.91 | 3.85 | 4.31 | 25.12 | 25.50 | |
Total Non Current Assets Annual | 10.24 | 9.15 | 6.99 | 39.00 | 35.28 | |
Total Current Assets Annual | 6759.37 | 6771.26 | 6770.03 | 6637.55 | 2490.28 | |
Total Assets Annual | 6769.61 | 6780.41 | 6777.02 | 6676.55 | 2525.56 | |
Contingent Liabilities plus Commitments Annual Cr | - | 8.26 | 8.39 | 8.15 | 8.16 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | -7.65 | -34.07 | 85.91 | -0.74 | 395.83 | |
Cash from Investing Activity Annual | 8.58 | 35.85 | -84.67 | 2.40 | -399.42 | |
Cash from Financing Annual Activity | -1.15 | -1.76 | -1.08 | -1.72 | 3.45 | |
Net Cash Flow Annual | - | 0.02 | 0.16 | -0.06 | -0.14 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 195.66 | 195.98 | 195.57 | 192.57 | 84.61 | |
ROE Annual % | -0.16 | 0.20 | 1.52 | 1.49 | 11.95 | |
ROCE Annual % | -0.16 | 0.28 | 2.17 | 1.94 | 16.37 | |
Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EBDIT Annual Margin % | -46.01 | 38.83 | 75.46 | 43.56 | 82.11 |
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 14898.52 | 12359.19 | 10189.14 | 9171.46 | 9934.23 | 8898.35 | 9322.59 | 3275.89 | 8962.31 | 6954.76 | 9327.37 | |
Operating Expenses Qtr | 14946.39 | 12146.97 | 10024.63 | 9043.59 | 9865.29 | 8573.40 | 9238.30 | 3185.37 | 8798.75 | 6842.92 | 9271.55 | |
Operating Profit Qtr | -58.63 | 209.36 | 143.86 | 124.97 | 63.93 | 322.25 | 77.97 | 86.75 | 160.76 | 111.19 | 55.23 | |
EBIDT Qtr Cr | -47.92 | 212.88 | 168.38 | 128.31 | 68.79 | 325.08 | 84.47 | 90.95 | 163.42 | 111.91 | 57.20 | |
Depreciation Qtr | 0.66 | 0.76 | 0.78 | 0.99 | 1.11 | 1.14 | 1.17 | 1.21 | 1.20 | 1.22 | 1.21 | |
Net Profit Qtr | -44.05 | 148.56 | 147.89 | 87.68 | 45.89 | 224.94 | 51.29 | 56.36 | 117.68 | 74.86 | 39.63 | |
Basic EPS Qtr | -1.28 | 4.30 | 4.29 | 2.54 | 1.33 | 6.52 | 1.49 | 1.63 | 3.41 | 2.55 | 1.15 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 46618.31 | 31431.06 | 31187.58 | 31288.01 | 18241.76 | |
Operating Expenses Annual Cr | 46156.66 | 30861.77 | 30769.19 | 30689.53 | 17787.63 | |
Operating Profit Annual | 419.56 | 550.91 | 411.95 | 584.37 | 452.35 | |
Operating Profit Margin Annual % | 0.90 | 1.75 | 1.32 | 1.87 | 2.48 | |
Total Expenses Annual Cr | 46203.49 | 30903.85 | 30798.92 | 30695.12 | 17799.28 | |
EBIDT Annual Cr | 461.65 | 569.29 | 418.39 | 598.48 | 454.14 | |
EBIDT Annual margin % | 0.99 | 1.81 | 1.34 | 1.91 | 2.49 | |
Depreciation | 3.19 | 4.63 | 5.00 | 5.32 | 11.37 | |
PAT Before ExtraOrdinary Items Annual Cr | 392.58 | 451.89 | 318.40 | 559.75 | 272.85 | |
Net Profit Annual | 340.08 | 378.49 | 253.37 | 425.39 | 144.99 | |
Basic EPS Annual | 9.85 | 10.97 | 7.34 | 14.51 | 5.38 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 3865.93 | 3518.24 | 3934.61 | 3342.96 | 2146.52 | |
Minority Interest Liability Annual Cr | 503.61 | 450.26 | 550.30 | 262.08 | 672.33 | |
Total Non Current Liabilities Annual Cr | 887.46 | 1363.38 | 846.09 | 73.17 | 138.11 | |
Total Current Liabilities Annual Cr | 157516.48 | 126491.90 | 112417.55 | 45.11 | 376.52 | |
Total Capital Plus Liabilities Annual Cr | 162773.48 | 131823.78 | 117748.55 | 98131.61 | 74526.22 | |
Fixed Assets Annual | 87.08 | 89.19 | 91.18 | 113.51 | 115.42 | |
Total Non Current Assets Annual | 2336.25 | 2211.58 | 1974.66 | 2973.95 | 3186.93 | |
Total Current Assets Annual | 160437.23 | 129612.20 | 115773.89 | 95157.66 | 71339.29 | |
Total Assets Annual | 162773.48 | 131823.78 | 117748.55 | 98131.61 | 74526.22 | |
Contingent Liabilities plus Commitments Annual Cr | - | 788.06 | 329.10 | 334.31 | 163.98 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 6106.95 | 9922.28 | 8495.86 | 8621.13 | 9467.54 | |
Cash from Investing Activity Annual | -5003.89 | -9227.65 | -8835.38 | -8580.55 | -9008.93 | |
Cash from Financing Annual Activity | -116.99 | -232.76 | 387.97 | -92.02 | -380.23 | |
Net Cash Flow Annual | - | 461.87 | 48.45 | -51.44 | 78.38 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 127.15 | 115.49 | 129.95 | 104.47 | 104.59 | |
ROE Annual % | 8.79 | 10.75 | 6.43 | 12.72 | 6.75 | |
ROCE Annual % | 8.72 | 10.59 | 7.75 | 0.60 | 0.59 | |
Total Debt to Total Equity Annual | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | |
EBDIT Annual Margin % | 0.99 | 1.81 | 1.34 | 1.91 | 2.48 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
HDFC MUTUAL FUND - HDFC NIFTY MIDCAP 150 INDEX FUND | 6.88 | 74517816 | - | - |
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE FUND | 3.22 | 74517819 | - | - |
ICICI PRUDENTIAL NIFTY FINANCIAL SERVICES EX-BANK ETF | 2.77 | 74517820 | - | - |
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE MULTI-CAP FUND | 1.58 | 74517821 | - | - |
CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO MID CAP FUND | 1.2 | 74517823 | - | - |
HDFC LIFE INSURANCE COMPANYLIMITED -SHAREHOLDERS SOLVENCY MARGIN ACCOUNT | 2.16 | 74517826 | - | - |
KOTAK FUNDS - INDIA MIDCAP FUND | 2.2 | 74517832 | - | - |
SMALLCAP WORLD FUND, INC | 1.73 | 74517835 | - | - |
NEW WORLD FUND INC | 1.26 | 74517836 | - | - |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
MAX VENTURES INVESTMENT HOLDINGS PRIVATE LIMITED | 6.4 | 74517813 | 70.47 | 0 |
Name | Holding Percent | Holding Id |
---|---|---|
HDFC MUTUAL FUND - HDFC NIFTY MIDCAP 150 INDEX FUND | 6.88 | 74517816 |
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA NIFTY MIDCAP 150 INDEX FUND | 5.86 | 74517817 |
MIRAE ASSET FLEXI CAP FUND | 4.92 | 74517818 |
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE FUND | 3.22 | 74517819 |
ICICI PRUDENTIAL NIFTY FINANCIAL SERVICES EX-BANK ETF | 2.77 | 74517820 |
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE MULTI-CAP FUND | 1.58 | 74517821 |
DSP ARBITRAGE FUND | 1.47 | 74517822 |
CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO MID CAP FUND | 1.2 | 74517823 |
INVESCO INDIA AGGRESSIVE HYBRID FUND | 1.01 | 74517824 |
KOTAK FUNDS - INDIA MIDCAP FUND | 2.2 | 74517832 |
WF ASIAN SMALLER COMPANIES FUND LIMITED | 2.01 | 74517833 |
NEW YORK LIFE INSURANCE COMPANY | 1.78 | 74517834 |
SMALLCAP WORLD FUND, INC | 1.73 | 74517835 |
NEW WORLD FUND INC | 1.26 | 74517836 |
KUWAIT INVESTMENT AUTHORITY FUND F238 | 1.11 | 74517837 |
HDFC LIFE INSURANCE COMPANYLIMITED -SHAREHOLDERS SOLVENCY MARGIN ACCOUNT | 2.16 | 74517826 |
TATA AIA LIFE INSURANCE COMPANY LIMITED A/C FLEXI GROWTH FUND ULIF 068 25/04/23 FGF 110 | 1.21 | 74517827 |
MITSUI SUMITOMO INSURANCE COMPANY LIMITED | 21.86 | 74517841 |
Name | Holding Percent | Holding Id |
---|
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Sep 19, 2016 | 1.8 | FINAL | - | Equity Share |
Nov 19, 2015 | 1.8 | INTERIM | Nov 20, 2015 | Equity Share |
Sep 15, 2015 | 1 | FINAL | - | Equity Share |
Nov 25, 2014 | 4 | INTERIM | Nov 26, 2014 | Equity Share |
Sep 12, 2014 | 1.8 | FINAL | - | Equity Share |
Nov 21, 2013 | 1.8 | INTERIM | Nov 22, 2013 | Equity Share |
Sep 10, 2013 | 2.2 | FINAL | - | Equity Share |
Nov 22, 2012 | 10 | INTERIM | Nov 23, 2012 | Equity Share |
Aug 23, 2001 | - | FINAL | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|---|---|
Mar 12, 2007 | 10:2 | 2007-03-19 |
Ex-Date | Purpose | Notes |
---|---|---|
Aug 13, 2024 | Quarterly Results | - |
May 07, 2024 | Audited Results | - |
Feb 06, 2024 | Quarterly Results | - |
Oct 31, 2023 | Quarterly Results | - |
Aug 09, 2023 | Quarterly Results | - |
May 12, 2023 | Audited Results | - |
Jan 31, 2023 | Quarterly Results | - |
Oct 19, 2022 | Quarterly Results | - |
Aug 01, 2022 | Quarterly Results | - |
May 10, 2022 | Audited Results | - |
Jan 28, 2022 | Quarterly Results | - |
Nov 09, 2021 | Quarterly Results | - |
Aug 10, 2021 | Quarterly Results | - |
Jun 08, 2021 | Audited Results | - |
Feb 09, 2021 | Quarterly Results | - |
Oct 30, 2020 | Quarterly Results | - |
Jul 30, 2020 | Quarterly Results | - |
May 26, 2020 | Audited Results | - |
Mar 03, 2020 | Preferential Issue of shares | Inter alia, to consider and approve (i) issuance of equity shares of the Company, on a preferential basis to Mitsui Sumitomo Insurance Company Limited (MSI), for consideration other than cash. |
Feb 05, 2020 | Quarterly Results | - |
Nov 06, 2019 | Quarterly Results | - |
Aug 06, 2019 | Quarterly Results | - |
May 28, 2019 | Audited Results | - |
Feb 11, 2019 | Quarterly Results | - |
Nov 14, 2018 | Quarterly Results | - |
Aug 06, 2018 | Quarterly Results | - |
May 25, 2018 | Audited Results | - |
Apr 09, 2018 | To consider raising of funds | - |
Mar 21, 2018 | To consider raising of funds | - |
Feb 09, 2018 | Quarterly Results & Others | - |
Nov 13, 2017 | Quarterly Results | - |
Aug 09, 2017 | Quarterly Results | - |
May 30, 2017 | Audited Results | - |
Feb 10, 2017 | Quarterly Results | - |
Nov 04, 2016 | Quarterly Results | - |
Aug 08, 2016 | Quarterly Results | Proposed scheme of arrangement amongst the Company, Max Life Insurance Company Limited (MLIC) and HDFC Life Insurance Company Limited and consequently, including Max India Limited. |
Jun 17, 2016 | Scheme of Arrangement | - |
May 30, 2016 | Audited Results & Final Dividend | - |
Mar 28, 2016 | Others | Appointment of Mr. Sanjay Omprakash Nayar as an Additional Director on the Board of Directors of the Company effective March 28, 2016 |
Feb 12, 2016 | Quarterly Results | - |
Jan 15, 2016 | Others | To discuss various matters arising from the Composite Scheme of Arrangement sanctioned by the Honble High Court of Punjab and Haryana at Chandigarh. |
Nov 23, 2015 | Others | To further strengthen the relationship with the JV partner in Max Bupa Health Insurance Company Ltd (Max Bupa), the Company has decided to divest 23% stake in Max Bupa in favour of Bupa Plc. UK. Bupa. |
Nov 06, 2015 | Quarterly Results & Interim Dividend | - |
Oct 23, 2015 | Others | To consider a proposal regarding its existing arrangements with Axis Bank as a shareholder of Max Life Insurance Company Limited. |
Aug 12, 2015 | Quarterly Results | - |
May 27, 2015 | Audited Results & Final Dividend | Mrs. Sujatha Ratnam, presently Senior Director-Corporate Finance is being appointed as the Chief Financial Officer of the Company. |
Feb 12, 2015 | Quarterly Results | - |
Jan 30, 2015 | Quarterly Results | - |
Jan 27, 2015 | Others | To review and approve the corporate restructuring plan for the Company |
Nov 12, 2014 | Quarterly Results & Interim Dividend | - |
Aug 13, 2014 | Quarterly Results | - |
May 28, 2014 | Audited Results & Final Dividend | - |
Feb 12, 2014 | Quarterly Results | - |
Nov 08, 2013 | Quarterly Results & Interim Dividend | - |
Aug 13, 2013 | Quarterly Results | - |
May 29, 2013 | Audited Results & Final Dividend | - |
Feb 08, 2013 | Quarterly Results | - |
Nov 09, 2012 | Quarterly Results & Special Dividend | - |
Aug 09, 2012 | Quarterly Results | - |
May 24, 2012 | Audited Results | - |
Apr 12, 2012 | Others | To sale of 9.37% stake in MNYL by the Company to MSI for an aggregate consideration of Rs. 9844.49 million & to purchase by the Company of 9.37% equity share capital of MNYL from NYLM at par value. |
Mar 22, 2012 | Others | 1. to enter into a related business in the area of "Senior Living". 3. making further investment of upto Rs. 240 Crs in the senior living business based on adequate liquidity position in the Company. |
Feb 14, 2012 | Quarterly Results & Others | Inter alia, consider the appointment of Mr. Mohit Talwar as the Deputy Managing Director of the Company. |
Nov 14, 2011 | Quarterly Results | (Revised) |
Aug 12, 2011 | Quarterly Results | - |
Jun 17, 2011 | Acquisition of Equity Shares | For acquisition of 47,617,924 Equity Shares of Rs.10/-each of Max Healthcare Institute Ltd., constituting the entire shareholding of 16.37% held by entities forming part of Warburg Pincus group. |
Jun 08, 2011 | Others | To consider the appointment of Mr. Rahul Khosla as the Managing Director of the Company. |
May 26, 2011 | Audited Results | - |
Feb 11, 2011 | Quarterly Results | - |
Oct 27, 2010 | Quarterly Results | - |
Jul 30, 2010 | Quarterly Results | - |
May 29, 2010 | Audited Results | - |
Mar 30, 2010 | Others | The Board has approved the proposal of MNYL, a 74:26 joint venture between the Company and New York Life International, LLC ('NYLI') to issue Equity Shares of approx. 4% of MNYL to Axis Bank. |
Mar 11, 2010 | Allotment of CCD's | The Board has approved allotment of 6,019,925 12% CCDs of Rs. 867/- each of the Company to Goldman Sachs Capital Partners through its WoS Xenok Ltd., for an aggr. consideration of Rs. 5,219,274,975/-. |
Jan 29, 2010 | Quarterly Results | - |
Dec 26, 2009 | To consider issue of Securities | To issue of such no. of FCD's of the face value of Rs. 867/- each to Goldman Sachs Capital Partners through its WoS Xenok Ltd. & to issue of 20,00,000 Warrants of the face value of Rs. 867/- each. |
Dec 22, 2009 | Others | The Board has appointed Mr. K. Narasimha Murthy and Dr. Omkar Goswami as Additional Directors of the Company effective December 22, 2009. |
Oct 30, 2009 | Quarterly Results | - |
Jul 30, 2009 | Quarterly Results | - |
Jul 01, 2009 | To consider Issue Equity Shares | To issue of equity shares or any such instruments/securities to QIB's under Chapter XIII-A of the SEBI (DIP) Guidelines, 2000, in one or more tranches, for an aggr. amt. of upto Rs.450,00,00,000/-. |
Jun 26, 2009 | Audited Results & Others | To approve the Audited Annual Accounts of the Company and consolidated annual financial results of the Company and its subsidiaries for the year ended March 31, 2009. |
May 15, 2009 | To issue of Equity Shares | To issue 10,326,311 equity shares of Rs 2/- each at a premium of Rs 143.26 per equity share, aggregating to Rs 150 Crores to International Finance Corporation, Washington, USA. |
Apr 23, 2009 | Others | To appoint Mr. Anuroop (Tony) Singh as the Non-Executive Vice Chairman of the Company, with effect from April 23, 2009. |
Feb 03, 2009 | Issue of securities on Rights basis | To issue of such no. of equity shares of the Co. of the face value of Rs 2/- each for cash for an amount not exceeding Rs 650 crores at such issue price, ratio. |
Jan 28, 2009 | Quarterly Results | - |
Dec 12, 2008 | Right Issue of Equity Shares | inter alia, to consider various fund raising proposals of the Company, including issuance of equity shares on Rights basis, to its shareholders. |
Oct 22, 2008 | Quarterly Results | - |
Jul 18, 2008 | Quarterly Results | - |
Jul 11, 2008 | To consider Joint venture arrangement | To consider and approve the joint venture arrangement with BUPA Finance Plc., UK for setting up a health insurance Company with 50% equity participation by Max India Ltd. |
May 17, 2008 | Audited Results | - |
Jan 28, 2008 | Quarterly Results | - |
Oct 29, 2007 | Quarterly Results | - |
Jul 31, 2007 | Quarterly Results | - |
Jun 15, 2007 | Allotment of equity shares | For allotment of equity shares to Qualified Institutional Buyers under Chapter XIII-A of the Securities & Exchange Board of India (Disclosure and Investor Protection) Guidelines, 2000. |
May 17, 2007 | Audited Results | - |
Feb 22, 2007 | To consider issue equity shares | To consider and approve the proposal to issue equity shares or any such instruments / securities to Qualified Institutional Buyers. |
Jan 24, 2007 | Quarterly Results & Stock Split | - |
Oct 30, 2006 | Quarterly Results | - |
Jul 31, 2006 | Quarterly Results | - |
Jun 29, 2006 | Accounts | - |
Jan 30, 2006 | Quarterly Results | - |
Dec 15, 2005 | Expansion & Amalgamation | Addition of a new BOPP film manufacturing line in Max Speciality Products a division of the Company with a capacity of 20,000 TPA; and The amalgamation of Max Asia-Pac Ltd, Hongkong, a WoS the Company |
Dec 05, 2005 | Amalgamation | To consider interalia, the proposal for amalgamation of Max Telecom Ventures Limited, a wholly-owned subsidiary with Max India Limited (the Company). |
Oct 25, 2005 | Quarterly Results | - |
Jul 29, 2005 | Quarterly Results | - |
Jun 29, 2005 | Quarterly Results & Accounts | - |
Jun 06, 2005 | Allotment of equity shares | Allotment of 59,49,300 equity shares of Rs 10/- each for cash at Rs 200/- each including a premium of Rs 190/- per equity share to Parkville Holdings Ltd., a member of the Warburg Pincus Group. |
Jan 31, 2005 | Others | To consider and approve the proposal to divest the entire equity stake hel by the company in its wholly-owned subsidiary, CMax Infocom Pvt. Ltd. in favour of Bharti Infotel Ltd. |
Jan 29, 2005 | Quarterly Results | - |
Jan 05, 2005 | Allotment of shares on Pref. basis | - |
Nov 24, 2004 | Preferential Offer | To consider the proposal for issue and allotment of equity shares, on preferential basis, to Madison Holding Ltd and Melany Holdings Ltd. |
Oct 27, 2004 | Quarterly Results | - |
Aug 11, 2004 | Others | Appointment of Mr. B. Anantharaman as the Joint Managing Director. |
Jul 27, 2004 | Quarterly Results | - |
Jun 29, 2004 | Accounts | - |
May 23, 2004 | Preferential Issue of shares | - |
Feb 13, 2004 | Preferential Issue | Issue of shares on preferential basis To consider and approve the proposal for issuance of equity shares, on preferential allotment basis, to ChrysCapital II LLC, Mauritius. |
Jan 29, 2004 | Quarterly Results | - |
Oct 31, 2003 | Quarterly Results | - |
Sep 26, 2003 | Others | Proposal to Divest 10820634 shares of Rs 10 each (64.99% ) stake held by the Company in Max Healthscribe Ltd in favour of its JV partner, Healthscribe Inc, USA. |
Jul 29, 2003 | Quarterly Results | - |
Jun 26, 2003 | Accounts | - |
Mar 21, 2003 | Others | Approve the proposal to invest in Max Healthstaff International Ltd. |
Feb 19, 2003 | Others | To consider the acquisition of 49% equity shares of Comsat Max Ltd. held by Comsat Investments Inc., Mauritius. |
Jan 28, 2003 | Quarterly Results | - |
Oct 29, 2002 | Quarterly Results | - |
Sep 04, 2002 | Divestment of Pharma Division | - |
Jul 31, 2002 | Accounts, Dividend & Quarterly Results | (Revised) |
Apr 29, 2002 | Quarterly Results & Others | Quarterly Results & To divestent of entire 40% shareholding of the company in Avnet Max Ltd., in favour of its Joint Venture partner, Avnet, USA. |
Apr 21, 2002 | Others | To consider the spin off its Healthcare business into a wholly owned subsidiary company. Divestment of balance 5% shareholding held by the company in DSM Anti-Infective India Pvt. Ltd. |
Jan 31, 2002 | Quarterly Results | - |
Dec 28, 2001 | Others | To proposal to make investment in a company (JVC) engaged in providing helthcare, medical and related services. |
Nov 19, 2001 | Others | To accept the resignation of Mr. Nripjit Singh Chawla as Managing Director (Healthcare) of the Company with effect from December 1, 2001. |
Oct 30, 2001 | Quarterly Results & Others | Quarterly Results & Appointment of Mr.Analjit Singh as Chairman & De-registration of the co. as a non-banking financial co. |
Jul 31, 2001 | Quarterly Results & Others | Spin off the Healthcare Division into a separate company. |
May 04, 2001 | Dividend, Accounts & Others | Divestment of the shareholding (50%) of the company in Max Atotech Ltd. to its joint venture partner, M/s.Atotech B.V. |
Jan 23, 2001 | Quarterly Results | - |
Oct 25, 2000 | Quarterly Results | - |
Oct 03, 2000 | Others | To take note of the resignation of Jagdish Anand from the Directorship and Appointment of Mr. Nripjit Singh Chawla and MD of the Company |
Sep 19, 2000 | Others | Approve certain proposals relating to organisational re-structuring. |
Aug 23, 2000 | Others | Investment by the Company in Dr. Lal's Pathlabs Pvt Ltd. & Investment in Instituto Cosmaticense de Investigaciones clinicas, Costa Rica |
Aug 04, 2000 | Others | To Consider in-principle approval for investment upto 74% in the equity cap |
Jul 31, 2000 | Quarterly Results (Revised) | - |
Jul 28, 2000 | Quarterly Results | - |
Apr 23, 2000 | Quarterly Results, Accounts & Final Div. | - |
Jan 17, 2000 | Quarterly Results | - |
Jan 16, 2000 | Quarterly Results & Bonus Issue | - |
Oct 11, 1999 | Quarterly Results | - |
Aug 21, 1999 | Merger | - |
Jul 31, 1999 | Quarterly Results, Accounts & Dividend | - |
May 31, 1999 | Accounts & Final Dividend (Revised) | - |
May 06, 1999 | Accounts & Dividend | - |
Feb 08, 1999 | Quarterly Results | - |
Nov 30, 1998 | Revised | - |
Nov 28, 1998 | Quarterly Results | - |
Aug 27, 1998 | Quarterly Results | - |
Aug 25, 1998 | Quarterly Results | - |
Jul 29, 1998 | Accounts | - |
May 23, 1998 | Interim Dividend | - |
Mar 30, 1998 | Conversion of warrants | - |
Nov 27, 1997 | Half Yearly Results | - |
Nov 26, 1997 | Half Yearly Results | - |
Jun 06, 1997 | Accounts | - |
Ex-Date | Bonus Ratio | Record Date |
---|---|---|
May 08, 2000 | 1:1 | 2000-05-27 |
Max Financial Services Ltd - 500271 - Closure of Trading Window
As per the disclosure attachedMax Financial Services Ltd - 500271 - Board Meeting Intimation for Disclosure Under Listing Regulations - Board Meeting For Consideration Of Un-Audited Financial Results Of The Company For The Quarter Ending June 30, 2024
Max Financial Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve In terms of Regulation 29 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 13, 2024, inter alia, to consider and approve the un-audited financial results of the Company (both standalone and consolidated) for the quarter ending on June 30, 2024.Max Financial Services Ltd - 500271 - Announcement under Regulation 30 (LODR)-Newspaper Publication
As per the disclosure attachedMax Financial Services Ltd - 500271 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual FundMax Financial Services Ltd - 500271 - Compliances-Reg.24(A)-Annual Secretarial Compliance
As per the report attached.Max Financial Services Ltd - 500271 - Announcement under Regulation 30 (LODR)-Investor Presentation
As per the disclosure attachedMax Financial Services Ltd - 500271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As per the disclosure attachedMax Financial Services Ltd - 500271 - Disclosure Under Listing Regulations - Grant Of Options
As per the disclosure attachedMax Financial Services Ltd - 500271 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
As per the disclosure attached.Max Financial Services Ltd - 500271 - Announcement under Regulation 30 (LODR)-Newspaper Publication
As per the disclosure attachedThe latest market price of Max Financial Services Ltd. on NSE was Rs. 1002.45 as of today.
The opening share price of Max Financial Services Ltd. was Rs. 1005.00 as of today.
The 52-week high share price of Max Financial Services Ltd. was Rs. 1092.00.
The 52 week low share price of Max Financial Services Ltd. was Rs. 763.00.
Max Financial Services Ltd. has a market cap of Rs. 34596.00 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Max Financial Services Ltd. is -10.00. Please refer to the Fundamentals section for further details.
The operating revenue for Max Financial Services Ltd. in the last FY was Rs. 46576.22 crore. Please refer to the Financials section for further details.
The Net Profit for Max Financial Services Ltd. in the last FY was Rs. 340.08 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Max Financial Services Ltd. was on 2016-09-19 for Rs. 1.8 per share. According to today’s share price, the dividend yield of Max Financial Services Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.
The latest bonus issue declared by Max Financial Services Ltd. was as of 2000-05-08. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Max Financial Services Ltd. was as of 2007-03-12. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Max Financial Services Ltd..